The processes include lowering insulin resistance and A toxicity, suppressing tau phosphorylation, resisting oxidative stress and neuroinflammation, providing anti-apoptotic action, controlling gut flora, alleviating blood–brain barrier damage and anti-endoplasmic reticulum stress response. The gene discussed is MAPT; the disease is Insulin resistance.